First-in-class positron emission tomography tracer for the glucagon receptor View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-12

AUTHORS

Irina Velikyan, Torsten Haack, Martin Bossart, Andreas Evers, Iina Laitinen, Philip Larsen, Oliver Plettenburg, Lars Johansson, Stefan Pierrou, Michael Wagner, Olof Eriksson

ABSTRACT

The glucagon receptor (GCGR) is emerging as an important target in anti-diabetic therapy, especially as part of the pharmacology of dual glucagon-like peptide-1/glucagon (GLP-1/GCG) receptor agonists. However, currently, there are no suitable biomarkers that reliably demonstrate GCG receptor target engagement. METHODS: Two potent GCG receptor peptide agonists, S01-GCG and S02-GCG, were labeled with positron emission tomography (PET) radionuclide gallium-68. The GCG receptor binding affinity and specificity of the resulting radiopharmaceuticals [68Ga]Ga-DO3A-S01-GCG and [68Ga]Ga-DO3A-S02-GCG were evaluated in HEK-293 cells overexpressing the human GCG receptor and on frozen hepatic sections from human, non-human primate, and rat. In in vivo biodistribution, binding specificity and dosimetry were assessed in rat. RESULTS: [68Ga]Ga-DO3A-S01-GCG in particular demonstrated GCG receptor-mediated binding in cells and liver tissue with affinity in the nanomolar range required for imaging. [68Ga]Ga-DO3A-S01-GCG binding was not blocked by co-incubation of a GLP-1 agonist. In vivo binding in rat liver was GCG receptor specific with low non-specific binding throughout the body. Moreover, the extrapolated human effective doses, predicted from rat biodistribution data, allow for repeated PET imaging potentially also in combination with GLP-1R radiopharmaceuticals. CONCLUSION: [68Ga]Ga-DO3A-S01-GCG thus constitutes a first-in-class PET tracer targeting the GCG receptor, with suitable properties for clinical development. This tool has potential to provide direct quantitative evidence of GCG receptor occupancy in humans. More... »

PAGES

17

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13550-019-0482-0

DOI

http://dx.doi.org/10.1186/s13550-019-0482-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112168851

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30771019


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "PET Centre, Centre for Medical Imaging, Uppsala University Hospital, Uppsala, Sweden", 
            "Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velikyan", 
        "givenName": "Irina", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Sanofi-Aventis Deutschland GmbH, Industriepark H\u00f6chst, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haack", 
        "givenName": "Torsten", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Sanofi-Aventis Deutschland GmbH, Industriepark H\u00f6chst, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bossart", 
        "givenName": "Martin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Sanofi-Aventis Deutschland GmbH, Industriepark H\u00f6chst, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evers", 
        "givenName": "Andreas", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Sanofi-Aventis Deutschland GmbH, Industriepark H\u00f6chst, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laitinen", 
        "givenName": "Iina", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Sanofi-Aventis Deutschland GmbH, Industriepark H\u00f6chst, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsen", 
        "givenName": "Philip", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Hannover", 
          "id": "https://www.grid.ac/institutes/grid.9122.8", 
          "name": [
            "Institute of Medicinal Chemistry, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany", 
            "Institute of Organic Chemistry, Leibniz Universit\u00e4t Hannover, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Plettenburg", 
        "givenName": "Oliver", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Antaros Medical AB, Uppsala Science Park, Dag Hammarskj\u00f6lds V\u00e4g 14B, M\u00f6lndal, SE-751 83, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Johansson", 
        "givenName": "Lars", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Antaros Medical AB, Uppsala Science Park, Dag Hammarskj\u00f6lds V\u00e4g 14B, M\u00f6lndal, SE-751 83, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pierrou", 
        "givenName": "Stefan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Sanofi-Aventis Deutschland GmbH, Industriepark H\u00f6chst, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner", 
        "givenName": "Michael", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Antaros Medical AB, Uppsala Science Park, Dag Hammarskj\u00f6lds V\u00e4g 14B, M\u00f6lndal, SE-751 83, Uppsala, Sweden", 
            "Science For Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eriksson", 
        "givenName": "Olof", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2337/db09-0278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000562521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10967-010-0555-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001584079", 
          "https://doi.org/10.1007/s10967-010-0555-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10967-010-0555-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001584079", 
          "https://doi.org/10.1007/s10967-010-0555-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2745-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002997915", 
          "https://doi.org/10.1007/s00259-014-2745-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/304368a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015042332", 
          "https://doi.org/10.1038/304368a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1363-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015567221", 
          "https://doi.org/10.1007/s00259-009-1363-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1363-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015567221", 
          "https://doi.org/10.1007/s00259-009-1363-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-014-3166-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034253462", 
          "https://doi.org/10.1007/s00125-014-3166-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-014-3166-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034253462", 
          "https://doi.org/10.1007/s00125-014-3166-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nchembio.209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037064127", 
          "https://doi.org/10.1038/nchembio.209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nchembio.209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037064127", 
          "https://doi.org/10.1038/nchembio.209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.112.114066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041683043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bc030078f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055153476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bc030078f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055153476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2013-3541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064294700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079103046", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/acs.jmedchem.7b00174", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085347683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-017-4354-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090855737", 
          "https://doi.org/10.1007/s00125-017-4354-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-017-4354-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090855737", 
          "https://doi.org/10.1007/s00125-017-4354-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-017-1046-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091514188", 
          "https://doi.org/10.1007/s00592-017-1046-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "The glucagon receptor (GCGR) is emerging as an important target in anti-diabetic therapy, especially as part of the pharmacology of dual glucagon-like peptide-1/glucagon (GLP-1/GCG) receptor agonists. However, currently, there are no suitable biomarkers that reliably demonstrate GCG receptor target engagement.\nMETHODS: Two potent GCG receptor peptide agonists, S01-GCG and S02-GCG, were labeled with positron emission tomography (PET) radionuclide gallium-68. The GCG receptor binding affinity and specificity of the resulting radiopharmaceuticals [68Ga]Ga-DO3A-S01-GCG and [68Ga]Ga-DO3A-S02-GCG were evaluated in HEK-293 cells overexpressing the human GCG receptor and on frozen hepatic sections from human, non-human primate, and rat. In in vivo biodistribution, binding specificity and dosimetry were assessed in rat.\nRESULTS: [68Ga]Ga-DO3A-S01-GCG in particular demonstrated GCG receptor-mediated binding in cells and liver tissue with affinity in the nanomolar range required for imaging. [68Ga]Ga-DO3A-S01-GCG binding was not blocked by co-incubation of a GLP-1 agonist. In vivo binding in rat liver was GCG receptor specific with low non-specific binding throughout the body. Moreover, the extrapolated human effective doses, predicted from rat biodistribution data, allow for repeated PET imaging potentially also in combination with GLP-1R radiopharmaceuticals.\nCONCLUSION: [68Ga]Ga-DO3A-S01-GCG thus constitutes a first-in-class PET tracer targeting the GCG receptor, with suitable properties for clinical development. This tool has potential to provide direct quantitative evidence of GCG receptor occupancy in humans.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13550-019-0482-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1045165", 
        "issn": [
          "2191-219X"
        ], 
        "name": "EJNMMI Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "First-in-class positron emission tomography tracer for the glucagon receptor", 
    "pagination": "17", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "15725580a4a58a438d85159f00df3f9a3a744c49270f51da0ffea63c17b5ba3e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30771019"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101560946"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13550-019-0482-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112168851"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13550-019-0482-0", 
      "https://app.dimensions.ai/details/publication/pub.1112168851"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000354_0000000354/records_11704_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13550-019-0482-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0482-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0482-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0482-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0482-0'


 

This table displays all metadata directly associated to this object as RDF triples.

190 TRIPLES      21 PREDICATES      43 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13550-019-0482-0 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author N1bf9f7070ca84c7ea21ba9a295a3e33b
4 schema:citation sg:pub.10.1007/s00125-014-3166-3
5 sg:pub.10.1007/s00125-017-4354-8
6 sg:pub.10.1007/s00259-009-1363-y
7 sg:pub.10.1007/s00259-014-2745-3
8 sg:pub.10.1007/s00592-017-1046-2
9 sg:pub.10.1007/s10967-010-0555-z
10 sg:pub.10.1038/304368a0
11 sg:pub.10.1038/nchembio.209
12 https://app.dimensions.ai/details/publication/pub.1079103046
13 https://doi.org/10.1021/acs.jmedchem.7b00174
14 https://doi.org/10.1021/bc030078f
15 https://doi.org/10.1210/jc.2013-3541
16 https://doi.org/10.2337/db09-0278
17 https://doi.org/10.2967/jnumed.112.114066
18 schema:datePublished 2019-12
19 schema:datePublishedReg 2019-12-01
20 schema:description The glucagon receptor (GCGR) is emerging as an important target in anti-diabetic therapy, especially as part of the pharmacology of dual glucagon-like peptide-1/glucagon (GLP-1/GCG) receptor agonists. However, currently, there are no suitable biomarkers that reliably demonstrate GCG receptor target engagement. METHODS: Two potent GCG receptor peptide agonists, S01-GCG and S02-GCG, were labeled with positron emission tomography (PET) radionuclide gallium-68. The GCG receptor binding affinity and specificity of the resulting radiopharmaceuticals [68Ga]Ga-DO3A-S01-GCG and [68Ga]Ga-DO3A-S02-GCG were evaluated in HEK-293 cells overexpressing the human GCG receptor and on frozen hepatic sections from human, non-human primate, and rat. In in vivo biodistribution, binding specificity and dosimetry were assessed in rat. RESULTS: [68Ga]Ga-DO3A-S01-GCG in particular demonstrated GCG receptor-mediated binding in cells and liver tissue with affinity in the nanomolar range required for imaging. [68Ga]Ga-DO3A-S01-GCG binding was not blocked by co-incubation of a GLP-1 agonist. In vivo binding in rat liver was GCG receptor specific with low non-specific binding throughout the body. Moreover, the extrapolated human effective doses, predicted from rat biodistribution data, allow for repeated PET imaging potentially also in combination with GLP-1R radiopharmaceuticals. CONCLUSION: [68Ga]Ga-DO3A-S01-GCG thus constitutes a first-in-class PET tracer targeting the GCG receptor, with suitable properties for clinical development. This tool has potential to provide direct quantitative evidence of GCG receptor occupancy in humans.
21 schema:genre research_article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N95347821202d4e5a94bf55f1caba8522
25 N9e6c2e17562249d2a07f70c30043d7cf
26 sg:journal.1045165
27 schema:name First-in-class positron emission tomography tracer for the glucagon receptor
28 schema:pagination 17
29 schema:productId N007a61bb3969467fb4536e2540bacfd3
30 N2d6a4d5cc11d46f580732e9403bad48e
31 N8c014f3fb9244d3194345de5a27fff98
32 N9d0bb3ccf80f4865b4329c131a9dcecb
33 Nfcbf83e2fa5a40688a190542a08034f0
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112168851
35 https://doi.org/10.1186/s13550-019-0482-0
36 schema:sdDatePublished 2019-04-11T11:18
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N04730831206f4542a53fbcf1f5319081
39 schema:url https://link.springer.com/10.1186%2Fs13550-019-0482-0
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N007a61bb3969467fb4536e2540bacfd3 schema:name readcube_id
44 schema:value 15725580a4a58a438d85159f00df3f9a3a744c49270f51da0ffea63c17b5ba3e
45 rdf:type schema:PropertyValue
46 N04730831206f4542a53fbcf1f5319081 schema:name Springer Nature - SN SciGraph project
47 rdf:type schema:Organization
48 N05eea876d438402287c11a84c7ebf53f schema:affiliation https://www.grid.ac/institutes/grid.8993.b
49 schema:familyName Velikyan
50 schema:givenName Irina
51 rdf:type schema:Person
52 N0e34c8e518f1457ebdecf15f01fd461f schema:affiliation Nbcd3ba57fab4464280f44f26cffcd3d4
53 schema:familyName Pierrou
54 schema:givenName Stefan
55 rdf:type schema:Person
56 N0ee3884336a44d95a367502b65f54fcc schema:affiliation https://www.grid.ac/institutes/grid.420214.1
57 schema:familyName Laitinen
58 schema:givenName Iina
59 rdf:type schema:Person
60 N1bf9f7070ca84c7ea21ba9a295a3e33b rdf:first N05eea876d438402287c11a84c7ebf53f
61 rdf:rest N94c265f55263419e99a3eaf0cecb5a3a
62 N2d6a4d5cc11d46f580732e9403bad48e schema:name nlm_unique_id
63 schema:value 101560946
64 rdf:type schema:PropertyValue
65 N396502fb0ad5442583ea9937313e8c9f schema:affiliation https://www.grid.ac/institutes/grid.8993.b
66 schema:familyName Eriksson
67 schema:givenName Olof
68 rdf:type schema:Person
69 N3d1b8ba7846a49eb9e1bc149cd6c5168 schema:affiliation https://www.grid.ac/institutes/grid.420214.1
70 schema:familyName Larsen
71 schema:givenName Philip
72 rdf:type schema:Person
73 N432fc642818745b7aa4bce9fdb067c8c rdf:first N3d1b8ba7846a49eb9e1bc149cd6c5168
74 rdf:rest N545dd968145345ae90e5f803623b1e9a
75 N481095088a814736bfb174d35c4a65eb schema:affiliation https://www.grid.ac/institutes/grid.420214.1
76 schema:familyName Wagner
77 schema:givenName Michael
78 rdf:type schema:Person
79 N4ca448360c5b4155af87e2dd6067f9c3 rdf:first N396502fb0ad5442583ea9937313e8c9f
80 rdf:rest rdf:nil
81 N50fc755aa18941b39d76d410390e04c1 rdf:first N8e31853a836a4e4f9d55cf6f4f32eee2
82 rdf:rest Nc84300d20503442b8a2e2462846615a8
83 N537be375a22542d597ae69eea586eb1d rdf:first N481095088a814736bfb174d35c4a65eb
84 rdf:rest N4ca448360c5b4155af87e2dd6067f9c3
85 N545dd968145345ae90e5f803623b1e9a rdf:first Na72b417fe6634308bfc3ff39cd2ace1e
86 rdf:rest N85dd98fbb2c74c78a7a49804d935a1ea
87 N85dd98fbb2c74c78a7a49804d935a1ea rdf:first Na250537b87534281ae7fe850e110b508
88 rdf:rest Ncc70ed3bd11240ab82b6e76e31ad2b9b
89 N8c014f3fb9244d3194345de5a27fff98 schema:name doi
90 schema:value 10.1186/s13550-019-0482-0
91 rdf:type schema:PropertyValue
92 N8e31853a836a4e4f9d55cf6f4f32eee2 schema:affiliation https://www.grid.ac/institutes/grid.420214.1
93 schema:familyName Evers
94 schema:givenName Andreas
95 rdf:type schema:Person
96 N940a3505013a403f8a724c9f9f2b4c54 schema:name Antaros Medical AB, Uppsala Science Park, Dag Hammarskjölds Väg 14B, Mölndal, SE-751 83, Uppsala, Sweden
97 rdf:type schema:Organization
98 N94c265f55263419e99a3eaf0cecb5a3a rdf:first Nb967682c03874827bd7a55eb99f33e2d
99 rdf:rest Nf076c501c68c419e851cc6e2307ba79e
100 N95347821202d4e5a94bf55f1caba8522 schema:issueNumber 1
101 rdf:type schema:PublicationIssue
102 N9d0bb3ccf80f4865b4329c131a9dcecb schema:name pubmed_id
103 schema:value 30771019
104 rdf:type schema:PropertyValue
105 N9e6c2e17562249d2a07f70c30043d7cf schema:volumeNumber 9
106 rdf:type schema:PublicationVolume
107 N9f44b91490f14971931d6cd3a769c2f7 schema:affiliation https://www.grid.ac/institutes/grid.420214.1
108 schema:familyName Bossart
109 schema:givenName Martin
110 rdf:type schema:Person
111 Na250537b87534281ae7fe850e110b508 schema:affiliation N940a3505013a403f8a724c9f9f2b4c54
112 schema:familyName Johansson
113 schema:givenName Lars
114 rdf:type schema:Person
115 Na72b417fe6634308bfc3ff39cd2ace1e schema:affiliation https://www.grid.ac/institutes/grid.9122.8
116 schema:familyName Plettenburg
117 schema:givenName Oliver
118 rdf:type schema:Person
119 Nb967682c03874827bd7a55eb99f33e2d schema:affiliation https://www.grid.ac/institutes/grid.420214.1
120 schema:familyName Haack
121 schema:givenName Torsten
122 rdf:type schema:Person
123 Nbcd3ba57fab4464280f44f26cffcd3d4 schema:name Antaros Medical AB, Uppsala Science Park, Dag Hammarskjölds Väg 14B, Mölndal, SE-751 83, Uppsala, Sweden
124 rdf:type schema:Organization
125 Nc84300d20503442b8a2e2462846615a8 rdf:first N0ee3884336a44d95a367502b65f54fcc
126 rdf:rest N432fc642818745b7aa4bce9fdb067c8c
127 Ncc70ed3bd11240ab82b6e76e31ad2b9b rdf:first N0e34c8e518f1457ebdecf15f01fd461f
128 rdf:rest N537be375a22542d597ae69eea586eb1d
129 Nf076c501c68c419e851cc6e2307ba79e rdf:first N9f44b91490f14971931d6cd3a769c2f7
130 rdf:rest N50fc755aa18941b39d76d410390e04c1
131 Nfcbf83e2fa5a40688a190542a08034f0 schema:name dimensions_id
132 schema:value pub.1112168851
133 rdf:type schema:PropertyValue
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
138 schema:name Pharmacology and Pharmaceutical Sciences
139 rdf:type schema:DefinedTerm
140 sg:journal.1045165 schema:issn 2191-219X
141 schema:name EJNMMI Research
142 rdf:type schema:Periodical
143 sg:pub.10.1007/s00125-014-3166-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034253462
144 https://doi.org/10.1007/s00125-014-3166-3
145 rdf:type schema:CreativeWork
146 sg:pub.10.1007/s00125-017-4354-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090855737
147 https://doi.org/10.1007/s00125-017-4354-8
148 rdf:type schema:CreativeWork
149 sg:pub.10.1007/s00259-009-1363-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1015567221
150 https://doi.org/10.1007/s00259-009-1363-y
151 rdf:type schema:CreativeWork
152 sg:pub.10.1007/s00259-014-2745-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002997915
153 https://doi.org/10.1007/s00259-014-2745-3
154 rdf:type schema:CreativeWork
155 sg:pub.10.1007/s00592-017-1046-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091514188
156 https://doi.org/10.1007/s00592-017-1046-2
157 rdf:type schema:CreativeWork
158 sg:pub.10.1007/s10967-010-0555-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1001584079
159 https://doi.org/10.1007/s10967-010-0555-z
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/304368a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015042332
162 https://doi.org/10.1038/304368a0
163 rdf:type schema:CreativeWork
164 sg:pub.10.1038/nchembio.209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037064127
165 https://doi.org/10.1038/nchembio.209
166 rdf:type schema:CreativeWork
167 https://app.dimensions.ai/details/publication/pub.1079103046 schema:CreativeWork
168 https://doi.org/10.1021/acs.jmedchem.7b00174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085347683
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1021/bc030078f schema:sameAs https://app.dimensions.ai/details/publication/pub.1055153476
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1210/jc.2013-3541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064294700
173 rdf:type schema:CreativeWork
174 https://doi.org/10.2337/db09-0278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000562521
175 rdf:type schema:CreativeWork
176 https://doi.org/10.2967/jnumed.112.114066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041683043
177 rdf:type schema:CreativeWork
178 https://www.grid.ac/institutes/grid.420214.1 schema:alternateName Sanofi (Germany)
179 schema:name Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany
180 rdf:type schema:Organization
181 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
182 schema:name Antaros Medical AB, Uppsala Science Park, Dag Hammarskjölds Väg 14B, Mölndal, SE-751 83, Uppsala, Sweden
183 PET Centre, Centre for Medical Imaging, Uppsala University Hospital, Uppsala, Sweden
184 Science For Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden
185 Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
186 rdf:type schema:Organization
187 https://www.grid.ac/institutes/grid.9122.8 schema:alternateName University of Hannover
188 schema:name Institute of Medicinal Chemistry, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
189 Institute of Organic Chemistry, Leibniz Universität Hannover, Hannover, Germany
190 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...